TRF-DOX (Faulk)

N/A

Report date: 2025/08/22 17:57:37

Base Information

Drug NameTRF-DOX (Faulk)
Drug Alias NameTransferrin DoxorubicinTransferrin-doxorubicin conjugateFP-TD1TRF-DOX
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase II inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsOvarian NeoplasmsHemangiosarcomaLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesProbility Media
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProbility Media
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsHemangiosarcomaLeukemia

Other Information

ATC CodeN/A
Related LinksN/A